Bellevue Life Sciences Acquisition (NASDAQ:BLAC) Shares Down 57.3% – Time to Sell?

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) shares traded down 57.3% during trading on Friday . The stock traded as low as $3.01 and last traded at $3.01. 398,513 shares traded hands during trading, an increase of 994% from the average session volume of 36,443 shares. The stock had previously closed at $7.05.

Bellevue Life Sciences Acquisition Trading Down 57.3 %

The firm has a fifty day simple moving average of $10.92 and a 200 day simple moving average of $10.97.

Institutional Trading of Bellevue Life Sciences Acquisition

An institutional investor recently raised its position in Bellevue Life Sciences Acquisition stock. Berkley W R Corp raised its stake in shares of Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) by 75.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 173,901 shares of the company’s stock after acquiring an additional 74,543 shares during the quarter. Berkley W R Corp owned approximately 4.30% of Bellevue Life Sciences Acquisition worth $1,887,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 55.30% of the company’s stock.

Bellevue Life Sciences Acquisition Company Profile

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.